Product Images Tamsulosin Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Tamsulosin Hydrochloride NDC 50436-0598 by Unit Dose Services, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label Image - lbl504360598
Drug description: Tamsulosin Hydrochloride AL, 0.4mg/30 capsules. Each capsule contains 0.4mg of Tamsulosin hydrochloride USP. The drug should be stored in a tight container and kept away from excessive moisture. The label also indicates the manufacturer's information, NDC code, dosage information as well as manufacturing information such as the LOT number and EXP date.*
Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-Dose Administration of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted and Fed Conditions (n=8) - tamsulosin fig1
The text provided is a figure caption showing a graph of the mean plasma concentration of Tamsulosin Hydrochloride Capsules at 0.4mg under fasted and fed conditions. The graph is divided into two parts, one for the fasted condition and another for the fed condition. The X-axis shows the time in hours and the Y-axis shows the plasma concentration. There is no additional information available in the given text.*
Figure 2A Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 1 - tamsulosin fig2
Figure 2B Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 2 - tamsulosin fig3
Figure 3A Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 1 - tamsulosin fig4
This is a figure from Study 1 showing the mean increase in peak urine flow rate (in L/sec) among different treatment groups. The treatments were 0.08 mg and 0.4 mg compared to a placebo. The mean change in flow rate is shown in mL/sec, with data collected over a period of 10 to 13 weeks (depending on the group). The figure includes a graph of the changes in flow rate over time.*
Figure 3B Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 2 - tamsulosin fig5
The text describes a figure labeled "Figure 3B" that shows the mean increase in peak urine flow rate in mL/sec for a study labeled "Study 2". The figure includes a graph with treatment listed on the x-axis and duration of treatment in weeks on the y-axis. However, there is no readable data or information related to the treatments, and the text is mostly made up of symbols and non-readable characters, so no further useful description can be generated.*
Chemical Structure - tamsulosin str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.